Ashland's Q3 2022 results showed strong sales growth of 19% year-over-year, driven by disciplined pricing and improved product mix. Adjusted EBITDA increased by 35% compared to the prior-year quarter. The company raised its outlook for sales and Adjusted EBITDA for the full fiscal year 2022.
Sales reached $644 million, a 19% increase from the prior-year quarter.
Net income was $36 million, or $0.65 per diluted share.
Adjusted income from continuing operations excluding intangibles amortization expense was $104 million, or $1.89 per diluted share.
Adjusted EBITDA was $174 million, up 35% from the prior-year quarter.
Ashland expects greater sales and Adjusted EBITDA in fiscal year 2022 compared to its previous outlook. Sales are expected to be in the range of $2.35 billion to $2.40 billion, and Adjusted EBITDA is expected to be in the range of $580 million to $590 million.
Visualization of income flow from segment revenue to net income